Bill Text: NJ SCR137 | 2020-2021 | Regular Session | Introduced
Bill Title: Urges Congress to enact legislation supporting research and access to potential therapies for the treatment of amyotrophic lateral sclerosis (ALS).
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2020-11-09 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [SCR137 Detail]
Download: New_Jersey-2020-SCR137-Introduced.html
SENATE CONCURRENT RESOLUTION No. 137
STATE OF NEW JERSEY
219th LEGISLATURE
INTRODUCED NOVEMBER 9, 2020
Sponsored by:
Senator VIN GOPAL
District 11 (Monmouth)
SYNOPSIS
Urges Congress to enact legislation supporting research and access to potential therapies for the treatment of amyotrophic lateral sclerosis (ALS).
CURRENT VERSION OF TEXT
As introduced.
A Concurrent Resolution urging Congress to enact legislation supporting research and access to potential therapies for the treatment of amyotrophic lateral sclerosis (ALS).
Whereas, Amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's Disease, is a progressive neurodegenerative disease that attacks nerve cells in the brain and spinal cord; and
Whereas, ALS strikes people between the ages of 40 and 70, and as many as 30,000 men and women in the United States have the disease at any given time; and
Whereas, There is presently no cure for ALS, and because most patients live for no more than two to five more years after they are first diagnosed with ALS, there is a heightened urgency in the need for new and improved treatment options; and
Whereas, Making additional funding available for research concerning the causes and potential treatments for ALS, and to support clinical trials for investigational ALS drugs, will provide support and hope to patients and their families struggling with the challenges of an ALS diagnosis; and
Whereas, Advancing research efforts, supporting and promoting investigational drug studies, and advancing new clinical studies may accelerate the development of more effective treatments for ALS or even a cure for the disease; and
Whereas, The enactment federal legislation will be an important step in the struggle to prevent, mitigate, and relieve patients and their families from the devastating effects ALS can have on the lives of people living with the disease and their families; now, therefore,
Be It Resolved by the Senate of the State of New Jersey (the General Assembly concurring):
1. The Legislature respectfully urges the United States Congress to enact legislation supporting research and access to potential therapies for the treatment of amyotrophic lateral sclerosis (ALS).
2. Copies of this resolution, as filed with the Secretary of State, shall be transmitted by the Secretary of the Senate or the Clerk of the General Assembly to Majority and Minority Leaders of the United States Senate, the Speaker and the Majority and Minority Leaders of the United States House of Representatives, and to each member of the United States Congress elected from the State of New Jersey.
STATEMENT
This concurrent resolution respectfully urges the Congress of the United States to enact legislation supporting research and access to potential therapies for the treatment of amyotrophic lateral sclerosis (ALS), in order to support efforts to prevent, mitigate, treat, or cure ALS.
Amyotrophic lateral sclerosis, which is also known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that attacks nerve cells in the brain and spinal cord. The disease strikes people between the ages of 40 and 70, and as many as 30,000 men and women in the United States have the disease at any given time. There is presently no cure for ALS.
It is the sponsor's belief that the enactment of federal legislation will be an important step in developing new treatments, preventative measures, or even a cure for ALS, bringing hope to the tens of thousands of people living with ALS and their families.
